North America Metabolic Disorder Therapeutics Market Size & Outlook
The metabolic disorder therapeutics market in North America is expected to reach a projected revenue of US$ 47,938.3 million by 2030. A compound annual growth rate of 7.7% is expected of North America metabolic disorder therapeutics market from 2025 to 2030.
Revenue, 2024 (US$M)
$30,804.1
Forecast, 2030 (US$M)
$47,938.3
CAGR, 2025 - 2030
7.7%
Report Coverage
North America
Related Markets
North America metabolic disorder therapeutics market highlights
- The North America metabolic disorder therapeutics market generated a revenue of USD 30,804.1 million in 2024.
- The market is expected to grow at a CAGR of 7.7% from 2025 to 2030.
- In terms of segment, diabetes was the largest revenue generating disease in 2024.
- Lysosomal Storage Diseases is the most lucrative disease segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 30,804.1 million |
| Market revenue in 2030 | USD 47,938.3 million |
| Growth rate | 7.7% (CAGR from 2025 to 2030) |
| Largest segment | Diabetes |
| Fastest growing segment | Lysosomal Storage Diseases |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Lysosomal Storage Diseases, Diabetes, Obesity, Inherited Metabolic Disorders, Hypercholesterolemia, Other Metabolic Diseases |
Other key industry trends
- In terms of revenue, North America region accounted for 39.9% of the global metabolic disorder therapeutics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 29,804.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metabolic Disorder Therapeutics Market Scope
Metabolic disorder therapeutics market segmentation & scope
Lysosomal Storage Diseases
Diabetes
Obesity
Inherited Metabolic Disorders
Hypercholesterolemia
Other Metabolic Diseases
Enzyme Replacement Therapy
Cellular Transplantation
Small Molecule Based Therapy
Substrate Reduction Therapy
Gene Therapy
Drug Therapy
Metabolic Disorder Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioMarin | View profile | - | - | - |
| Novo Nordisk A/S | View profile | - | - | - |
| Biocon | View profile | 10001+ | Bangalore, Karnataka, India, Asia | http://www.biocon.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
North America metabolic disorder therapeutics market size, by country, 2018-2030 (US$M)
North America Metabolic Disorder Therapeutics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
